Renal Cell Cancer Update
Optimizing the Identification of HER2-Low Breast Cancer
- Autor: Vários
- Narrador: Vários
- Editora: Podcast
- Duração: 0:23:48
- Mais informações
Informações:
Sinopse
Dr Kimberly H Allison from the Stanford Cancer Institute in Stanford, California discusses the optimal identification, pathologic reporting and treatment of HER2-low breast cancer, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here (https://www.researchtopractice.com/OncologyTodayTestingHER2LowBC24).
